Spesolimab Post-marketing Surveillance in Korean Patients With Flares With Generalized Pustular Psoriasis

NCT06886009 · clinicaltrials.gov ↗

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Generalized Pustular Psoriasis

Interventions

DRUG: Spevigo®

Sponsor

Boehringer Ingelheim